---
$id: https://graph.org.ai/products/commodity/51151627
$type: Product
source: UNSPSC
code: "51151627"
title: "Chlorbenzoxamine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Chlorbenzoxamine

**UNSPSC Code**: 51151627
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N52918SLYN. European Medicines Agency schedules Chlorbenzoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06176MIG. Chlorbenzoxamine generally arises in the molecular formula C27H31CLN2O. The term CHLORBENZOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) CHLORBENZOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorbenzoxamine under HS 29335995 and SITC 51576. As of Q4 2014, CHLORBENZOXAMINE remains the US FDA Preferred Term for this commodity. Chlorbenzoxamine bears US NLM identifiers UMLS ID C2699179 and NCI Concept Code C79940. SMILES: CLC1C(C(OCCN2CCN(CC2)CC2C(CCCC2)C)C2CCCCC2)CCCC1.

